Cytological and molecular characterization of secretory breast carcinoma

por Carretero‐Barrio, Irene, Santón, Almudena, Caniego Casas, Tamara, López Miranda, Elena, Reguero‐Callejas, Maria Eugenia, Pérez‐Mies, Belén, Benito, Amparo, Palacios, José
Publicado 2022

High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features

por Rosa-Rosa, Juan Manuel, Caniego-Casas, Tamara, Leskela, Susanna, Cristobal, Eva, González-Martínez, Silvia, Moreno-Moreno, Esther, López-Miranda, Elena, Holgado, Esther, Pérez-Mies, Belén, Garrido, Pilar, Palacios, José
Publicado 2019

A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer

por Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Malfettone, Andrea, López-Miranda, Elena, Gion, María, Abad, Elena, Alcalá-López, Daniel, Pérez-Escuredo, Jhudit, Pérez-García, José Manuel, Llombart-Cussac, Antonio, Cortés, Javier
Publicado 2023

Maintained complete response to talazoparib in a BRCA-2 mutated metastatic luminal breast cancer: case report and review of literature

por Albarrán, Víctor, Chamorro, Jesús, Pozas, Javier, San Román, María, Rosero, Diana Isabel, Saavedra, Cristina, Gion, María, Cortés, Alfonso, Escalera, Elena, Guerra, Eva, López Miranda, Elena, Fernández Abad, María, Martínez Jañez, Noelia
Publicado 2023

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design

por Sampayo-Cordero, Miguel, Miguel-Huguet, Bernat, Pérez-García, José, Páez, David, Guerrero-Zotano, Ángel L., Garde-Noguera, Javier, Aguirre, Elena, Holgado, Esther, López-Miranda, Elena, Huang, Xin, Malfettone, Andrea, Llombart-Cussac, Antonio, Cortés, Javier
Publicado 2020

Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inh...

por Saavedra, Cristina, Vallejo, Alejandro, Longo, Federico, Serrano, Juan José, Fernández, María, Gion, María, López-Miranda, Elena, Martínez-Jáñez, Noelia, Guerra, Eva, Chamorro, Jesús, Rosero, Diana, Velasco, Héctor, Martín, Adrián, Carrato, Alfredo, Casado, José Luis, Cortés, Alfonso
Publicado 2023

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial

por López-Miranda, Elena, Pérez-García, José Manuel, Di Cosimo, Serena, Brain, Etienne, Ravnik, Maja, Escrivá-de-Romaní, Santiago, Vidal, Maria, Gligorov, Joseph, Borštnar, Simona, Calabuig, Laura, Sampayo-Cordero, Miguel, Malfettone, Andrea, Llombart-Cussac, Antonio, Suter, Thomas M., Cortés, Javier
Publicado 2020

Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study

por López González, Ana, Del Barco Berrón, Sonia, Grau, Isabel, Galan, Maria, Castelo Fernández, Beatriz, Cortés, Alfonso, Sánchez Rovira, Pedro, Martinez-Bueno, Alejandro, Gonzalez, Xavier, García, Almudena, Gener, Petra, Mina, Leonardo, Alcalá-López, Daniel, Sampayo, Miguel, Cortés, Javier, Pérez-Garcia, José Manuel, Llombart-Cussac, Antonio, López-Miranda, Elena
Publicado 2022

Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study

por de la Cruz-Merino, Luis, Gion, María, Cruz-Jurado, Josefina, Quiroga, Vanesa, Andrés, Raquel, Moreno, Fernando, Alonso-Romero, Jose L., Ramos, Manuel, Holgado, Esther, Cortés, Javier, López-Miranda, Elena, Henao-Carrasco, Fernando, Palazón-Carrión, Natalia, Rodríguez, Luz M., Ceballos, Isaac, Casas, Maribel, Benito, Sara, Chiesa, Massimo, Bezares, Susana, Caballero, Rosalia, Jiménez-Cortegana, Carlos, Sánchez-Margalet, Víctor, Rojo, Federico
Publicado 2021

A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors

por Hanna, Glenn J., Stathis, Anastasios, Lopez-Miranda, Elena, Racca, Fabricio, Quon, Doris, Leyvraz, Serge, Hess, Dagmar, Keam, Bhumsuk, Rodon, Jordi, Ahn, Myung-Ju, Kim, Hye Ryun, Schneeweiss, Andreas, Ribera, Josep-Maria, DeAngelo, Daniel, Perez Garcia, Jose Manuel, Cortes, Javier, Schönborn-Kellenberger, Oliver, Weber, Dirk, Pisa, Pavel, Bauer, Michael, Beni, Laura, Bobadilla, Maria, Lehal, Raj, Vigolo, Michele, Vogl, Florian D., Garralda, Elena
Publicado 2023

Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments

por Cortés, Alfonso, Casado, José L., Longo, Federico, Serrano, Juan J., Saavedra, Cristina, Velasco, Héctor, Martin, Adrián, Chamorro, Jesús, Rosero, Diana, Fernández, María, Gion, María, Martínez Jáñez, Noelia, Soria Rivas, Ainara, Alonso Gordoa, Teresa, Martínez Delfrade, Íñigo, Lage, Yolanda, López Miranda, Elena, Olmedo, María E., Reguera Puertas, Pablo, Gajate, Pablo, Molina Cerrillo, Javier, Guerra Alia, Eva, Fuentes Mateos, Raquel, Romero, Beatriz, Rodríguez-Domínguez, Mario J., Vallejo, Alejandro, Carrato, Alfredo
Publicado 2022